What Is Biomarker? Definition for Peptide Research

Types of Biomarkers

By Function

Type	Purpose	Example
Diagnostic	Identify disease	HbA1c for diabetes
Prognostic	Predict outcome	Tumor markers
Predictive	Predict treatment response	Receptor status
Pharmacodynamic	Measure drug effect	IGF-1 after GH secretagogue
Safety	Monitor adverse effects	Liver enzymes

By Nature

Type	Example
Molecular	Blood glucose, IGF-1, HbA1c
Imaging	Body composition DEXA scans
Physiological	Blood pressure, heart rate
Clinical	Weight, waist circumference

Biomarkers in Peptide Research

GLP-1 Agonist Studies

Biomarker	What It Measures
HbA1c	Long-term glucose control
Fasting glucose	Immediate glucose status
Body weight	Primary efficacy (obesity)
Waist circumference	Central adiposity
Blood pressure	Cardiovascular effect
Lipid panel	Metabolic health

Growth Hormone Secretagogue Studies

Biomarker	What It Measures
IGF-1	GH pathway activation
IGFBP-3	GH axis marker
GH levels	Direct effect (but pulsatile)
Body composition	Lean mass, fat mass

Surrogate vs Clinical Endpoints

Surrogate Endpoint

Biomarker that predicts clinical benefit
Allows faster drug approval
Example: HbA1c predicts diabetes complications

Clinical Endpoint

Direct measure of patient outcome
How patient feels, functions, or survives
Example: Heart attack, stroke, death

Biomarker Validation

For a biomarker to be useful:

Criterion	Meaning
Analytical validity	Accurate, reproducible measurement
Clinical validity	Correlates with disease/outcome
Clinical utility	Changes treatment decisions

Not all biomarkers are validated for all purposes.

Using Biomarkers in Drug Development

Preclinical
    ↓ Identify candidate biomarkers
Phase I
    ↓ Test biomarker response to drug
Phase II
    ↓ Validate biomarker-effect relationship
Phase III
    ↓ Use biomarkers as endpoints
Post-approval
    ↓ Monitor real-world biomarker changes

Biomarkers and Personalized Medicine

Biomarkers can help:

Identify who will respond to treatment
Predict side effects
Guide dose adjustments
Monitor treatment effectiveness

Common Biomarkers in Metabolic Peptide Research

Biomarker	Normal Range	Significance
HbA1c	<5.7%	Diabetes control
Fasting glucose	<100 mg/dL	Metabolic health
IGF-1	Varies by age	GH axis function
hsCRP	<3 mg/L	Inflammation
ALT/AST	<40 U/L	Liver safety

Frequently Asked Questions

Can I track my own biomarkers?

Yes, some biomarkers are available through standard lab tests or home monitoring (blood glucose, blood pressure). Others require specialized testing. Tracking biomarkers can help assess treatment effectiveness but should be interpreted with healthcare provider guidance.

Why not just use clinical outcomes in trials?

Clinical outcomes (heart attacks, deaths) are relatively rare and take years to accumulate. Biomarkers allow faster studies with fewer participants. They’re particularly useful in early trials and for accelerated drug approval pathways.

What makes a good biomarker for drug development?

It should be: easily measured, reproducible, clearly related to the drug’s mechanism, predictive of clinical outcomes, and change in response to treatment within a reasonable timeframe.

Biomarker